Anming Ruan

426 total citations
7 papers, 337 citations indexed

About

Anming Ruan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Anming Ruan has authored 7 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cancer Research and 1 paper in Oncology. Recurrent topics in Anming Ruan's work include MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (3 papers). Anming Ruan is often cited by papers focused on MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (3 papers). Anming Ruan collaborates with scholars based in China, United States and Israel. Anming Ruan's co-authors include Xiaoping Zhang, Hongmei Yang, Xuegang Wang, Xuanyu Chen, Weiwei Han, Pei Xiao, Li Chen, Yan Zhao, Quansheng Du and Rong Wang and has published in prestigious journals such as Clinical Cancer Research, Molecular Cancer Research and Oncology Reports.

In The Last Decade

Anming Ruan

7 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anming Ruan China	6	293	246	90	25	15	7	337
Tangliang Zhao China	8	287 1.0×	251 1.0×	71 0.8×	30 1.2×	12 0.8×	10	361
Roy Nofech‐Mozes Canada	7	287 1.0×	223 0.9×	126 1.4×	35 1.4×	14 0.9×	8	357
Weinan Xue China	12	208 0.7×	193 0.8×	81 0.9×	73 2.9×	23 1.5×	17	309
Zhi Lu China	5	360 1.2×	350 1.4×	21 0.2×	23 0.9×	11 0.7×	7	416
Xiaoyou Li China	8	287 1.0×	258 1.0×	62 0.7×	46 1.8×	12 0.8×	10	356
Kristen M. Foss United States	3	298 1.0×	298 1.2×	70 0.8×	49 2.0×	7 0.5×	4	380
Zongjiang Luo China	10	252 0.9×	232 0.9×	47 0.5×	47 1.9×	15 1.0×	19	321

Countries citing papers authored by Anming Ruan

Since Specialization

Citations

This map shows the geographic impact of Anming Ruan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anming Ruan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anming Ruan more than expected).

Fields of papers citing papers by Anming Ruan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anming Ruan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anming Ruan. The network helps show where Anming Ruan may publish in the future.

Co-authorship network of co-authors of Anming Ruan

This figure shows the co-authorship network connecting the top 25 collaborators of Anming Ruan. A scholar is included among the top collaborators of Anming Ruan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anming Ruan. Anming Ruan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Chen, Xuanyu, Ning Lou, Anming Ruan, et al.. (2018). miR‑224/miR‑141 ratio as a novel diagnostic biomarker in renal cell carcinoma. Oncology Letters. 16(2). 1666–1674. 19 indexed citations

2.

Lou, Ning, Anming Ruan, Bin Qiu, et al.. (2016). miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 35(1). 36.e7–36.e14. 45 indexed citations

3.

Wang, Xuegang, Xuanyu Chen, Weiwei Han, et al.. (2015). miR-200c Targets CDK2 and Suppresses Tumorigenesis in Renal Cell Carcinoma. Molecular Cancer Research. 13(12). 1567–1577. 37 indexed citations

4.

Chen, Xuanyu, Xuegang Wang, Anming Ruan, et al.. (2014). miR-141 Is a Key Regulator of Renal Cell Carcinoma Proliferation and Metastasis by Controlling EphA2 Expression. Clinical Cancer Research. 20(10). 2617–2630. 127 indexed citations

5.

Chen, Xuanyu, Anming Ruan, Xuegang Wang, et al.. (2014). miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes. Journal of Cancer Research and Clinical Oncology. 140(8). 1295–1304. 64 indexed citations

6.

Wang, Xuegang, Xuanyu Chen, Rong Wang, et al.. (2013). microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis. Oncology Reports. 30(2). 643–650. 40 indexed citations

7.

Yang, Hongmei, Xuanyu Chen, Xuegang Wang, et al.. (2013). Inhibition of PP2A Activity Confers a TRAIL-Sensitive Phenotype during Malignant Transformation. Molecular Cancer Research. 12(2). 217–227. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tangliang Zhao Breakdown of academic impact, for papers by Roy Nofech‐Mozes Breakdown of academic impact, for papers by Weinan Xue Breakdown of academic impact, for papers by Zhi Lu Breakdown of academic impact, for papers by Xiaoyou Li Breakdown of academic impact, for papers by Kristen M. Foss Breakdown of academic impact, for papers by Zongjiang Luo